Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen’s Playing To Its R&D Strengths, Which No Longer Include Neuroscience
Oct 30 2019
•
By
Mandy Jackson
180 Amgen jobs will be cut as the company ends early neuroscience R&D. • Source: Shutterstock
More from Neurological
More from Therapeutic Category